Yanli Jin

Summary

Country: China

Publications

  1. pmc Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl
    Zhongzheng Lu
    Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat Sen University, Guangzhou, PR China
    Mol Cancer 9:112. 2010

Detail Information

Publications1

  1. pmc Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl
    Zhongzheng Lu
    Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat Sen University, Guangzhou, PR China
    Mol Cancer 9:112. 2010
    ..CML blasts have constitutive p65 (RelA NF-kappaB) transcriptional activity, and NF-kappaB may be a potential target for molecular therapies in CML that may also be effective against CML cells with Bcr-Abl-T315I...